Papillomavirus umano

Papilloma squamoso e lesione linguale

2025/6 — pag. 399 — DOI

La vaccinazione anti-papillomavirus: mai più senza!

Russo R, Marchetti F.

2024/9 — pag. 575-582 — DOI

Human papillomavirus is the most common sexually transmitted infection in the world. Most HPV infections resolve spontaneously within 2 years from infection; however, persistent infection may result in a wide array of diseases, ranging from genital w...

Verruche piane Eczema dell’areola e del capezzolo

2023/2 — pag. 132 — DOI

Parliamo di sesso

2022/5 — pag. 283 — DOI

Pitiriasi lichenoide varioliforme acuta Verruche genitali

2020/5 — pag. 332-332

Le verruche

G. Paloni, I. Berti

2015/8 — pag. 520-522

Warts are benign intraepidermal lesions caused by human papillomavirus infection that commonly affects children and adolescents. The 4 most frequent types of cutaneous warts are common warts, plantar warts, flat warts, and genital warts. Although t...

Il Pap-test? Certamente! La vaccinazione anti-HPV? Sì, eventualmente

M. Bonati

2008/4 — pag. 251-253

Human papillomavirus (HPV) is associated with an increased risk of cervical cancer. However, only a few infected women develop cervical carcinoma. Combined cytology and HPV DNA screening are effective preventive interventions. Today, two vaccines a...

Il vaccino contro il papillomavirus umano: efficacia dichiarata ed efficacia dimostrata

S. Di Mario, M. Bergamini, D. Spettoli, V. Basevi, N. Magrini

2007/9 — pag. 562-571

The recent introduction in the European market of the tetravalent vaccine against Human Papillomavirus raises some concerns on the opportunity to start a national vaccination campaign. In this article an analysis of the currently available evidence, ...

Il vaccino per il cancro della cervice

Agenzia Italiana del Farmaco

2007/4

Il nuovo calendario USA per le vaccinazioni nel 2007

G. Bartolozzi

2007/2

Il vaccino contro i papillomavirus per la prevenzione del cancro delcollo dell'utero e dei conditomi acuminati

G. Bartolozzi

2007/2